» Articles » PMID: 24744588

HLA Variants Related to Primary Sclerosing Cholangitis Influence Rejection After Liver Transplantation

Overview
Specialty Gastroenterology
Date 2014 Apr 19
PMID 24744588
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate influence of human leukocyte antigen (HLA) and killer immunoglobuline-like receptor (KIR) genotypes on risks of acute rejection (AR) after liver transplantation (LTX).

Methods: In this retrospective study we included 143 adult donor-recipient pairs with a minimum of 6 mo follow-up after LTX for whom DNA was available from both donor and recipients. Clinical data, all early complications including episodes and severity of AR and graft/patient survival were registered. The diagnosis of AR was based on clinical, biochemical and histological criteria. All suspected episodes of AR were biopsy confirmed. Key classical HLA loci (HLA-A, HLA-B, HLA-C and HLA-DRB1) were genotyped using Sanger sequencing. 16 KIR genes were genotyped using a novel real time PCR approach which allows for determination of the diploid copy number of each KIR gene. Immunohistochemical staining for T (CD3), B (CD20) and natural killer (NK) cells (CD56 and CD57) were performed on liver biopsies from 3 different patient groups [primary sclerosing cholangitis (PSC), primary biliary cirrhosis and non-autoimmune liver disease], 10 in each group, with similar grade of AR.

Results: Fourty-four (31%) patients were transplanted on the basis of PSC, 40% of them had AR vs 24% in the non-PSC group (P = 0.04). No significant impact of donor-recipient matching for HLA and KIR genotypes was detected. In the overall recipient population an increased risk of AR was detected for HLA-B*08 (P = 0.002, OR = 2.5; 95%CI: 1.4-4.6), HLA-C*07 (P = 0.001, OR = 2.4; 95%CI: 1.4-4.0) and HLA-DRB1*03 (P = 0.03, OR = 1.9; 95%CI: 1.0-3.3) and a decreased risk for HLA-DRB1*04 (P = 0.001, OR = 0.2; 95%CI: 0.1-0.5). For HLA-B*08, HLA-C*07 and DRB1*04 the associations remained evident in a subgroup analysis of non-PSC recipients (P = 0.04, P = 0.003 and P = 0.02, respectively). In PSC recipients corresponding P values were 0.002, 0.17 and 0.01 for HLA-B*08, HLA-C*07 and DRB1*04, respectively. A dosage effect of AR prevalence according to the PSC associated HLA alleles was also notable in the total recipient population. For HLA-B*08 the frequency of AR was 56% in HLA-B*08 homozygous recipients, 39% in heterozygous recipients and 21% in recipients lacking HLA-B*08 (P = 0.02). The same was observed for the HLA-C*07 allele with AR in 57%, 27% and 18% in recipients being homozygous, heterozygous and lacking HLA-C*07 respectively (P = 0.003). Immunohistochemical analysis showed similar infiltration of T, B and NK cells in biopsies with AR in all three groups.

Conclusion: We found significant associations between the PSC-associated HLA-B*08, HLA-C*07, HLA-DRB1*03 and HLA-DRB1*04 alleles and risk of AR in liver transplant recipients.

Citing Articles

Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management.

Triantafyllou E, Gudd C, Possamai L Nat Rev Gastroenterol Hepatol. 2024; 22(2):112-126.

PMID: 39663461 DOI: 10.1038/s41575-024-01019-7.


"HLA-C: evolution, epigenetics, and pathological implications in the major histocompatibility complex".

Velastegui E, Vera E, Vanden Berghe W, Munoz M, Orellana-Manzano A Front Genet. 2023; 14:1206034.

PMID: 37465164 PMC: 10350511. DOI: 10.3389/fgene.2023.1206034.


Serological biomarkers for management of primary sclerosing cholangitis.

Tornai D, Ven P, Lakatos P, Papp M World J Gastroenterol. 2022; 28(21):2291-2301.

PMID: 35800183 PMC: 9185217. DOI: 10.3748/wjg.v28.i21.2291.


KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease.

Debska-Zielkowska J, Moszkowska G, Zielinski M, Zielinska H, Dukat-Mazurek A, Trzonkowski P Cells. 2021; 10(7).

PMID: 34359951 PMC: 8303609. DOI: 10.3390/cells10071777.


Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry.

Ma Y, Su H, Yuksel M, Longhi M, McPhail M, Wang P Hepatology. 2021; 74(4):2032-2046.

PMID: 33971035 PMC: 8463472. DOI: 10.1002/hep.31893.


References
1.
Hov J, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M . Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C. J Hepatol. 2010; 52(5):712-7. DOI: 10.1016/j.jhep.2009.11.029. View

2.
Hindorff L, Sethupathy P, Junkins H, Ramos E, Mehta J, Collins F . Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009; 106(23):9362-7. PMC: 2687147. DOI: 10.1073/pnas.0903103106. View

3.
Bathgate A, Pravica V, Perrey C, Therapondos G, Plevris J, Hayes P . The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation. 2000; 69(7):1514-7. DOI: 10.1097/00007890-200004150-00054. View

4.
Legaz I, Lopez-Alvarez M, Campillo J, Moya-Quiles M, Bolarin J, de la Pena J . KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury. Transplantation. 2013; 95(8):1037-44. DOI: 10.1097/TP.0b013e318286486c. View

5.
Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok C . The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev. 1999; 167:257-74. DOI: 10.1111/j.1600-065x.1999.tb01398.x. View